EUR 115.88 For Business Accounts Only

PX'Therapeutics SAS - Company Review

PX'Therapeutics SAS - Company Review

Summary

PX’Therapeutics SAS (PX'Therapeutics), formerly Protein’eXpert SA, a subsidiary of Laboratoire Aguettant is a contract research and manufacturing organization that offers development and bioproduction of therapeutic antibodies. The organization provides recombinant proteins, drug substance, murine mAB, monoclonal antibodies, industrial enzymes, ancillary products, analytics, GMP, in-vivo and in-vitro diagnostics products, and drug products. Its services include proteins and antibodies research and development, feasibility studies, cell line and process development, GMP manufacturing, protein engineering, humanization services, multiple expression systems screening, and monoclonal antibody characterization. PX'Therapeutics also provides animal immunization, hybridomas fusion and generation, secreting hybridomas screening and cloning, antibody batches purification, absolute protein quantification, protein and cell bank characterization, and contract research services. The organization serves academic institutions and biotechnology companies. PX'Therapeutics is headquartered in Grenoble, France.

This comprehensive company report of PX'Therapeutics SAS provides you with company's businesses and operations information.

The profile contains critical company information including,

- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.